LPL Financial’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
67,586
-61,571
-48% -$2.6M ﹤0.01% 3682
2026
Q1
$7.14M Buy
129,157
+12,466
+11% +$593K ﹤0.01% 2306
2025
Q4
$4.36M Sell
116,691
-1,595
-1% -$64.8K ﹤0.01% 2652
2025
Q3
$4.79M Sell
118,286
-8,541
-7% -$282K ﹤0.01% 2497
2025
Q2
$3.24M Sell
126,827
-1,508
-1% -$32.9K ﹤0.01% 2672
2025
Q1
$2.74M Buy
128,335
+40,889
+47% +$914K ﹤0.01% 2666
2024
Q4
$1.84M Buy
87,446
+35,053
+67% +$811K ﹤0.01% 2940
2024
Q3
$1.18M Buy
+52,393
New +$1.01M ﹤0.01% 3235

Other funds holding PAHC

LPL Financial's PAHC Position: Q2 2026 in Review

LPL Financial reduced its Phibro Animal Health (PAHC) stake by 48% in Q2 2026, selling an estimated $2.6M and leaving 67,586 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3682.

LPL Financial first reported a position in PAHC in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.14M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • LPL Financial held 67,586 shares of Phibro Animal Health worth $2.12M as of Q2 2026.
  • LPL Financial sold 61,571 Phibro Animal Health shares in Q2 2026, an estimated $2.6M.
  • Phibro Animal Health made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3682 holding.
  • LPL Financial first reported a position in Phibro Animal Health in Q3 2024 and has held it in 8 quarters since.
  • LPL Financial's Phibro Animal Health position peaked at $7.14M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.